4 Key Takeaways As Opioid MDL Distributors Seek Judge's DQ
Law360 (September 16, 2019, 10:49 PM EDT) -- An out-of-the-blue crusade by drug distributors and pharmacies to disqualify the judge supervising multidistrict opioid litigation has little chance of succeeding, but it could lay the foundation for future challenges to the judge's sweeping rejection of legal defenses, experts say.
U.S. District Judge Dan Aaron Polster of the Northern District of Ohio, who is facing a disqualification bid by drug distributors and pharmacies in opioid litigation. (AP) The unexpected broadside Saturday contended that U.S. District Judge Dan Aaron Polster's longtime fixation on settling the epic MDL and his stated goal of easing the opioid crisis have created the appearance of bias,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!